998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT studyOliver Klein, M.S. Carlino, Bo Gao et al.|Annals of Oncology|2024Cited by 1
1544P A phase II trial of palbociclib and avelumab in advanced solid tumours with CDK4/6 pathway alterationsM. Kansara, D. Thomas, Theresa M. Corpuz et al.|Annals of Oncology|2025Cited by 1
996P Phase II trial of alectinib in ALK-altered solid tumours and NSCLC with negative standard care testing: Australian molecular screening and therapeutics (MoST) substudy 14Frank Lin, D. Thomas, M. Itchins et al.|Annals of Oncology|2025Cited by 0